These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3349966)

  • 41. Fluctuations of plasma phenytoin levels on single dose and twice daily dose regimes.
    Vajda FJ; Merory J; Bladin PF
    Proc Aust Assoc Neurol; 1975; 12():61-4. PubMed ID: 1215397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epilepsy and pregnancy: a prospective study of seizure control in relation to free and total plasma concentrations of carbamazepine and phenytoin.
    Tomson T; Lindbom U; Ekqvist B; Sundqvist A
    Epilepsia; 1994; 35(1):122-30. PubMed ID: 8112234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phenytoin pharmacokinetics: before and after folic acid administration.
    Berg MJ; Fincham RW; Ebert BE; Schottelius DD
    Epilepsia; 1992; 33(4):712-20. PubMed ID: 1628589
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum concentrations and enzyme induction in epileptic children treated with phenytoin and valproate.
    de Wolff FA; Peters AC; van Kempen GM
    Neuropediatrics; 1982 Feb; 13(1):10-3. PubMed ID: 6123089
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sensitivity and specificity of the association between catamenial seizure patterns and ovulation.
    Herzog AG; Fowler KM;
    Neurology; 2008 Feb; 70(6):486-7. PubMed ID: 18250294
    [No Abstract]   [Full Text] [Related]  

  • 46. Catamenial epilepsy.
    Penovich PE; Helmers S
    Int Rev Neurobiol; 2008; 83():79-90. PubMed ID: 18929076
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsy.
    Ortega-Vázquez A; Dorado P; Fricke-Galindo I; Jung-Cook H; Monroy-Jaramillo N; Martínez-Juárez IE; Familiar-López I; Peñas-Lledó E; LLerena A; López-López M
    Pharmacogenomics J; 2016 Jun; 16(3):286-92. PubMed ID: 26122019
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hormones and seizures.
    Foldvary-Schaefer N; Harden C; Herzog A; Falcone T
    Cleve Clin J Med; 2004 Feb; 71 Suppl 2():S11-8. PubMed ID: 15379295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lack of sister chromatid exchange induction in phenytoin-treated patients with epilepsy.
    Schaumann BA; Winge VB; Garry VF
    Epilepsia; 1989; 30(2):240-5. PubMed ID: 2924749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenytoin dosage adjustment in Saudi epileptics: utilization of steady-state pharmacokinetic parameters.
    Abduljabbar M; Al-Khamis K; Ogunniyi A; Daif AK; Al-Yamani M
    Eur J Neurol; 1999 May; 6(3):331-4. PubMed ID: 10210914
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of seizure type on the efficacy of plasma concentrations of phenytoin, phenobarbital, and carbamazepine.
    Schmidt D; Einicke I; Haenel F
    Arch Neurol; 1986 Mar; 43(3):263-5. PubMed ID: 3947275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial.
    Ramsay E; Faught E; Krumholz A; Naritoku D; Privitera M; Schwarzman L; Mao L; Wiegand F; Hulihan J;
    Epilepsia; 2010 Oct; 51(10):1970-7. PubMed ID: 20633037
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dose adjustment of phenytoin for comedication in Japanese patients with epilepsy.
    Fukuoka N; Uno J; Tsukamoto T; Houchi H; Kimura M; Morita S
    Ther Drug Monit; 2009 Feb; 31(1):57-62. PubMed ID: 19077928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: studies in stereoselective hydroxylation and population pharmacokinetics.
    Mamiya K; Ieiri I; Shimamoto J; Yukawa E; Imai J; Ninomiya H; Yamada H; Otsubo K; Higuchi S; Tashiro N
    Epilepsia; 1998 Dec; 39(12):1317-23. PubMed ID: 9860067
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduced plasma nisoldipine concentrations in phenytoin-treated patients with epilepsy.
    Michelucci R; Cipolla G; Passarelli D; Gatti G; Ochan M; Heinig R; Tassinari CA; Perucca E
    Epilepsia; 1996 Nov; 37(11):1107-10. PubMed ID: 8917062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spotlight on the continual applicability of routine plasma monitoring antiepileptic drugs in the treatment of epilepsy.
    El Desoky E; Kandil MR; Afifi AH; Mostafa OA
    Pharmacol Res; 1999 Apr; 39(4):269-74. PubMed ID: 10208756
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Variability of phenytoin, carbamazepine and valproate concentrations in a clinic population.
    Leppik IE
    Epilepsy Res Suppl; 1988; 1():85-90. PubMed ID: 3149581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Catamenial epilepsy: gynecological and hormonal implications. Five case reports.
    Rodriguez Macias KA
    Gynecol Endocrinol; 1996 Apr; 10(2):139-42. PubMed ID: 8701789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy.
    Epilepsia; 1998 Sep; 39(9):952-9. PubMed ID: 9738674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of felbamate on phenytoin and carbamazepine serum concentrations.
    Graves NM; Holmes GB; Fuerst RH; Leppik IE
    Epilepsia; 1989; 30(2):225-9. PubMed ID: 2647472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.